Clinical trial
Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and…
NCT00169858 · Laval University, Other · Completed
Key facts
| NCT number | NCT00169858 |
|---|---|
| Title | Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster Injections |
| Official title | Open Randomised Clinical Study of the Long Term Immunogenicity of Engerix-B in 10 Year Old Children and of the Effect of Booster Injections Given 5, 10 or 15 Years After Primary Vaccination |
| Lead sponsor | Laval University, Other |
| Collaborators | Institut National en Santé Publique du Québec Centre de Recheche du Centre Hospitalier Université Laval SmithKlinBeecham Biologicals |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hepatitis B, Vaccination |
| Intervention type | Biological |
| Interventions | Engerix-B |
| Enrollment | 1,129 |
| Start date | Sep 1, 1995 |
| Primary completion | Oct 1, 2011 |
| Completion | May 1, 2012 |
| First posted | Sep 15, 2005 |
| Last update posted | May 29, 2013 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: